BlackRock Health Sciences Trust II (BMEZ)vsBerkshire Hathaway Inc (BRK-B)
BMEZ
BlackRock Health Sciences Trust II
$14.01
+0.07%
FINANCIAL SERVICES · Cap: $880.64M
BRK-B
Berkshire Hathaway Inc
$474.07
-0.28%
FINANCIAL SERVICES · Cap: $1.03T
Smart Verdict
WallStSmart Research — data-driven comparison
BRK-B leads profitability with a 18.0% profit margin vs 0.0%. BMEZ trades at a lower P/E of 5.5x. BRK-B earns a higher WallStSmart Score of 54/100 (C-).
BMEZ
Avoid30
out of 100
Grade: F
BRK-B
Buy54
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Mega-cap, among the largest globally
Reasonable price relative to book value
Strong operational efficiency at 33.0%
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Generating 5.0B in free cash flow
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
Revenue declined 0.7%
Earnings declined 2.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio.
Bull Case : BRK-B
The strongest argument for BRK-B centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 18.0% and operating margin at 33.0%.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Bear Case : BRK-B
The primary concerns for BRK-B are Piotroski F-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
BMEZ profiles as a value stock while BRK-B is a declining play — different risk/reward profiles.
BMEZ is growing revenue faster at 0.0% — sustainability is the question.
BRK-B generates stronger free cash flow (5.0B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BRK-B scores higher overall (54/100 vs 30/100), backed by strong 18.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund strategically managed to achieve high total returns through a diversified portfolio concentrated in the health sciences sector, including pharmaceuticals, biotechnology, and medical devices. Leveraging the extensive expertise of BlackRock, a premier global investment manager, BMEZ targets significant growth opportunities driven by demographic trends and rising healthcare expenditures. Its disciplined investment strategy positions the fund as an attractive option for institutional investors aiming to enhance their portfolios while capitalizing on the evolving landscape of health sciences innovation.
Berkshire Hathaway Inc
FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA
Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).
Visit Website →Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?